Ain Medicare Sdn Bhd
Ain Medicare is a Malaysian sterile parenteral pharmaceutical manufacturer founded in 1993, producing intravenous solutions, injectables, and haemodialysis concentrates for Malaysian government and private healthcare providers, with exports to 17 countries.
- Company typePrivate
- Founded1993
- HeadquartersKota Bharu, Malaysia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ain Medicare Sdn Bhd does
Ain Medicare Sdn Bhd is a Malaysian pharmaceutical manufacturer founded in 1993 and headquartered in Kota Bharu, Kelantan. The company specializes in sterile parenteral pharmaceutical products across three core lines: intravenous solutions, injectables, and haemodialysis concentrates. These products serve Malaysian government and private healthcare providers domestically, with international exports reaching 17 countries. The underlying technology is aseptic sterile parenteral manufacturing, a specialized domain requiring stringent GMP compliance and regulatory approvals from NPRA Malaysia and equivalent foreign regulators.
The business model is straightforward B2B pharmaceutical product sales: Ain Medicare manufactures sterile parenteral products and supplies them directly to healthcare providers through enterprise field sales channels. Revenue is generated from product unit sales rather than subscriptions or licensing. The go-to-market is dual-track, combining domestic direct supply to government hospitals and private healthcare facilities with international export distribution. In April 2026, Ekuinas (Ekuiti Nasional Berhad) acquired a strategic minority stake through its RM1 billion Tranche IV fund, explicitly earmarked for growth and expansion of international footprint and product offerings under Malaysia's 'Bumiputera Relay Race' mandate to scale Bumiputera-owned enterprises in strategic sectors.
The company is led by CEO Dr. Syed Ibrahim Bin Mohd and Founder & Chairman Dato' Wan Ariff Bin Wan Hamzah, with a workforce of 501-1000 employees supporting manufacturing and distribution operations. Prior growth capital was provided by VentureTECH in February 2018. Ain Medicare operates within Malaysia's pharmaceutical sector, which is projected to grow at approximately 6.4% annually to over RM15 billion by 2030.
Ain Medicare Sdn Bhd firmographics
Firmographics- Name
- Ain Medicare Sdn Bhd
- Legal name
- Ain Medicare Sdn Bhd
- Website
- https://ainmedicare.com.my
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Ain Medicare is a Malaysian sterile parenteral pharmaceutical manufacturer founded in 1993, producing intravenous solutions, injectables, and haemodialysis concentrates for Malaysian government and private healthcare providers, with exports to 17 countries.
- Ownership category
- akta.pro rank
Where Ain Medicare Sdn Bhd is headquartered
LocationHeadquarters
- HQ city
- Kota Bharu
- HQ country
- Malaysia
- HQ region
- Asia
Offices1 record
Markets served
Ain Medicare Sdn Bhd business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Ain Medicare generates revenue through the manufacture and sale of sterile parenteral pharmaceutical products including intravenous solutions, injectables, and haemodialysis concentrates to government and private healthcare providers domestically and internationally.
Go-to-market motion1 record
Distribution channels2 records
Ain Medicare Sdn Bhd product offering
Product offeringCore offering
Ain Medicare is a home-grown Malaysian pharmaceutical manufacturer founded in 1993 that produces sterile parenteral pharmaceutical products. Its portfolio spans three core product lines — intravenous solutions, injectables, and haemodialysis concentrates — which it supplies directly to Malaysian government and private healthcare providers, and exports to healthcare providers across 17 countries.
Product overview
Ain Medicare Sdn Bhd is a Malaysian pharmaceutical manufacturer founded in 1993, headquartered in Kota Bharu, Kelantan. The company operates as a home-grown manufacturer of sterile parenteral pharmaceutical products, offering a portfolio of three core product lines: Intravenous Solutions, Injectables, and Haemodialysis Concentrates. These products are supplied to Malaysian government and private healthcare providers, with the company maintaining an international footprint exporting to 17 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Intravenous Solutions
Quantifiable outcome
- Serves healthcare providers across 17 export countries
- +1 more outcomes
Companies that use Ain Medicare Sdn Bhd
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
Ain Medicare Sdn Bhd technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Ain Medicare Sdn Bhd partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Ain Medicare Sdn Bhd competitors and assessment
Company assessmentDirect peers
- Pharmaniaga Berhad: Malaysia's largest integrated pharmaceutical company, manufacturing generics and supplying the Ministry of Health. Directly comparable given its Malaysian domicile, government healthcare customer base, and sterile manufacturing capabilities.
- Hovid Berhad: Malaysian pharmaceutical manufacturer with global export presence in generics and finished dosage forms. Comparable as a home-grown Malaysian pharma manufacturer with international exports and B2B supply to healthcare providers.
- Duopharma Biotech Berhad: Malaysian-based pharmaceutical manufacturer supplying government hospitals and private healthcare providers domestically and regionally. Directly comparable as a home-grown Malaysian pharma manufacturer with government channel exposure and similar product categories.
Emerging players
- Terumo Corporation: Japanese medical technology company with a hospital and medical products division that includes pre-filled syringes and injectable delivery. Comparable as a player in the injectables category serving hospitals across Asia, though more device-oriented.
Broad incumbents
- Fresenius Kabi: Global leader in IV generic drugs, clinical nutrition, and medical devices, with significant sterile injectables and IV solutions production. Comparable as a multinational incumbent directly competing in the same product categories as Ain Medicare.
- B. Braun Melsungen AG: Global German medical and pharmaceutical company with a major sterile solutions, IV, and dialysis product portfolio. Comparable as a large incumbent in sterile parenteral solutions and haemodialysis consumables, though with much broader geographic reach.
- Baxter International: US-headquartered global healthcare company with leading positions in IV solutions, injectable drugs, and renal therapy including dialysis products. Comparable as a multinational incumbent in the exact product categories Ain Medicare serves.
Regional players
- Sichuan Kelun Pharmaceutical: Chinese sterile injectable manufacturer with a large infusion and injectable drug portfolio, active in emerging Asian markets. Comparable as an Asian-headquartered competitor in sterile parenteral manufacturing serving similar hospital channels.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Ain Medicare Sdn Bhd social profiles
Digital presenceAin Medicare Sdn Bhd financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ain Medicare Sdn Bhd leadership team
Management profileNumber of profiles
Profiles2 records
Ain Medicare Sdn Bhd funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ain Medicare Sdn Bhd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ain Medicare Sdn Bhd
What does Ain Medicare Sdn Bhd do?
Ain Medicare is a home-grown Malaysian pharmaceutical manufacturer founded in 1993 that produces sterile parenteral pharmaceutical products. Its portfolio spans three core product lines — intravenous solutions, injectables, and haemodialysis concentrates — which it supplies directly to Malaysian government and private healthcare providers, and exports to healthcare providers across 17 countries.
Is Ain Medicare Sdn Bhd a public or private company?
Ain Medicare Sdn Bhd is a private company. It is classified as private equity controlled and is currently operating.
When was Ain Medicare Sdn Bhd founded?
Ain Medicare Sdn Bhd was founded in 1993. It employs 101 to 250 people.
Where is Ain Medicare Sdn Bhd based?
Ain Medicare Sdn Bhd is headquartered in Kota Bharu, Malaysia, in the Asia region.
How does Ain Medicare Sdn Bhd make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Ain Medicare Sdn Bhd's main competitors?
Direct peers on record are Pharmaniaga Berhad, Hovid Berhad and Duopharma Biotech Berhad. Terumo Corporation is listed as an emerging player. Broad incumbents are Fresenius Kabi, B. Braun Melsungen AG and Baxter International. Sichuan Kelun Pharmaceutical is listed as a regional player.
Does Ain Medicare Sdn Bhd have an API?
No public API is recorded for Ain Medicare Sdn Bhd.